On this page
Rebyota
fecal microbiota, live-jslm
351(a) Standalone BLA
Overview
Source: Purple BookProprietary name
Rebyota
Proper name
fecal microbiota, live-jslm
Licence type
351(a)
BLA number
125739
Applicant
Ferring Pharmaceuticals Inc.
Center
CBER
Presentations
1
First licensure
November 30, 2022
Presentations
Source: Purple Book| Strength | Dosage form | Route | Presentation | Status | Licensed |
|---|---|---|---|---|---|
| BETWEEN 1X10^8 AND 5X10^10CFU | Suspension | Rectal | Single-Use Bottle | Rx | November 30, 2022 |
Exclusivity
Source: Purple Book| Kind | Expires |
|---|---|
| Orphan exclusivity | November 30, 2029 |
Sources for this page
| Purple Book | FDA | Licence type, presentations, reference product, exclusivity |